[67 gallium in tumour diagnosis (author's transl)].

Fortschr Geb Rontgenstr Nuklearmed

Published: April 1974

Download full-text PDF

Source

Publication Analysis

Top Keywords

[67 gallium
4
gallium tumour
4
tumour diagnosis
4
diagnosis author's
4
author's transl]
4
[67
1
tumour
1
diagnosis
1
author's
1
transl]
1

Similar Publications

 This article evaluates whether parameters derived from the gallium-68-labeled prostate-specific membrane antigen ( Ga-PSMA) positron emission tomography/computed tomography (PET/CT) imaging studies of primary prostate cancer (PCa) lesions were associated with Gleason score (GS), D'Amico risk class, Candiolo nomograms, and the metastatic status of the disease.  We retrospectively evaluated newly diagnosed PCa patients who underwent Ga-PSMA PET/CT before therapy. Age, baseline serum prostate-specific antigen (PSA), and metastatic status were recorded.

View Article and Find Full Text PDF
Article Synopsis
  • The long-term effects and treatment of acute kidney injury (AKI) from the red yeast rice supplement Benikoji CholesteHelp are not fully understood, but three cases of renal dysfunction improved after stopping the supplement.
  • In the first case, a 59-year-old woman developed severe renal impairment and Fanconi syndrome after 7 months of use, but her kidney function gradually improved over three months post-discontinuation, though not back to baseline levels.
  • The other two cases involved men aged 48 and 47 who experienced mild renal dysfunction after taking the supplement for 2 and 4 months, respectively, both of which showed significant improvement after stopping the supplement, indicating that discontinuation may reverse renal impairment in these scenarios.
View Article and Find Full Text PDF

Background: The NOTI chelating scaffold can readily be derivatized for bioconjugation without impacting its metal complexation/radiolabeling properties making it an attractive building block for the development of multimeric/-valent radiopharmaceuticals. The objective of the study was to further explore the potential of the NOTI chelating platform by preparing and characterizing homotrimeric PSMA radioconjugates in order to identify a suitable candidate for clinical translation.

Results: Altogether, three PSMA conjugates based on the NOTI-TVA scaffold with different spacer entities between the chelating unit and the Glu-CO-Lys PSMA binding motif were readily prepared by solid phase-peptide chemistry.

View Article and Find Full Text PDF

Purpose: Ga-Trivehexin is a PET tracer targeting αvβ6-integrin, a transmembrane receptor that is frequently expressed by pancreatic cancer cells. This study aimed to determine the biokinetics, image contrast, and acquisition parameters for Ga-Trivehexin PET imaging in pancreatic cancers.

Methods: 44 patients with pancreatic cancer underwent Trivehexin PET/CT between June 2021 and November 2022 (EK-242052023).

View Article and Find Full Text PDF

Positron Emission Tomography Imaging of Cathepsin B in Tumors with Activable Small Molecule Tracers.

J Med Chem

December 2024

NHC Key Laboratory of Nuclear Medicine, Jiangsu Key Laboratory of Molecular Nuclear Medicine, Jiangsu Institute of Nuclear Medicine, Wuxi 214063, China.

Cathepsin B (CTB) is overexpressed in several types of tumors, and precise evaluation of the CTB activity can offer a promising method for the early diagnosis of tumors. In this study, two CTB-activated positron emission tomography (PET) tracers, and , were developed for sensitive and specific detection of CTB. Both tracers undergo a click condensation between 2-cyano-6-aminobenzothiazole (CBT) and cysteine (Cys) to form a cyclization product, thereby enhancing and prolonging the PET signal in tumors.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!